Pfizer Inc. shares declined 1.7% on Thursday after the company revealed that Chief Financial Officer Dave Denton will resign and depart the company on August 15. The company said Denton is leaving to accept a professional opportunity outside the pharmaceutical industry in consumer goods.
Effective August 16, Pfizer named Cecile Guegan as Interim Chief Financial Officer. Guegan currently serves as Senior Vice President, Finance, Global Biopharmaceutical Business. The company said it will carry out a comprehensive search both internally and externally to identify a permanent CFO. The announcement noted that Denton and Guegan will collaborate to ensure an orderly transition.
Albert Bourla, Pfizer’s Chairman and Chief Executive Officer, credited Denton with steady stewardship of the company’s financial position, singling out his role during several major corporate transactions. The company’s statement listed the acquisitions of Seagen, Biohaven and Metsera as examples of deals in which Denton provided financial leadership.
Guegan brings more than two decades of experience at Pfizer. In her current role she oversees the financial operations and reporting for Pfizer’s biopharmaceutical business across therapeutic areas and geographies, and has held global finance leadership responsibilities that include work across therapeutic areas, research and development and multiple regions.
Speaking on his departure, Denton said it had been an honor to work at Pfizer during a meaningful period in the company’s history. He added that the company is in "excellent hands" with the existing executive leadership team.
The company’s immediate actions - appointing an experienced internal finance leader as interim CFO while initiating a thorough search - are intended to provide continuity in financial management. Investors reacted to the personnel change with an immediate share-price decline, reflecting at least short-term market sensitivity to changes in top financial leadership.
Contextual note: The company will combine internal and external candidate searches for a permanent CFO, and Denton and Guegan will work together through the handover period to support continuity in financial oversight.